EP1166112A4 - Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same - Google Patents

Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same

Info

Publication number
EP1166112A4
EP1166112A4 EP00921123A EP00921123A EP1166112A4 EP 1166112 A4 EP1166112 A4 EP 1166112A4 EP 00921123 A EP00921123 A EP 00921123A EP 00921123 A EP00921123 A EP 00921123A EP 1166112 A4 EP1166112 A4 EP 1166112A4
Authority
EP
European Patent Office
Prior art keywords
quantifying
beta
same
growth factor
transforming growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00921123A
Other languages
German (de)
French (fr)
Other versions
EP1166112A1 (en
Inventor
Seung Won Jin
Hoon Shin
Chang-Gi Lim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of EP1166112A1 publication Critical patent/EP1166112A1/en
Publication of EP1166112A4 publication Critical patent/EP1166112A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]
EP00921123A 1999-04-09 2000-04-10 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same Withdrawn EP1166112A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19990012568 1999-04-09
KR9912568 1999-04-09
KR9943935 1999-10-12
KR19990043935 1999-10-12
PCT/KR2000/000329 WO2000062062A1 (en) 1999-04-09 2000-04-10 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME

Publications (2)

Publication Number Publication Date
EP1166112A1 EP1166112A1 (en) 2002-01-02
EP1166112A4 true EP1166112A4 (en) 2004-11-10

Family

ID=26634921

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00921123A Withdrawn EP1166112A4 (en) 1999-04-09 2000-04-10 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same

Country Status (11)

Country Link
EP (1) EP1166112A4 (en)
JP (1) JP2002541479A (en)
CN (1) CN1355882A (en)
AU (1) AU768029B2 (en)
BR (1) BR0009607A (en)
CA (1) CA2369892A1 (en)
ID (1) ID30316A (en)
MX (1) MXPA01009942A (en)
NZ (1) NZ514596A (en)
TR (1) TR200102917T2 (en)
WO (1) WO2000062062A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2430257A1 (en) * 2000-11-28 2002-06-06 Amgen, Inc. Transforming growth factor-beta-related molecules and uses thereof
JP4834835B2 (en) * 2006-07-27 2011-12-14 国立大学法人浜松医科大学 Diagnostic agent for autism

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010215A1 (en) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Purified proteoglycan betaglycan, compositions, and methods
WO1997013844A1 (en) * 1995-10-06 1997-04-17 Cambridge Antibody Technology Limited Specific binding members for human transforming growth factor beta; materials and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59195162A (en) * 1983-04-21 1984-11-06 Toyo Jozo Co Ltd Reagent for assay of transforming gross factor
JPS59216058A (en) * 1983-05-23 1984-12-06 Toyo Jozo Co Ltd Determining method of transforming gross factor
JPS59226864A (en) * 1983-06-07 1984-12-20 Toyo Jozo Co Ltd Method for measuring enzyme immune of transforming gross factor
JPS6018764A (en) * 1983-07-12 1985-01-30 Toyo Jozo Co Ltd Immunological measurement of transforming growth factor
JPH02126157A (en) * 1988-11-04 1990-05-15 Tosoh Corp Method for immunologically measuring human transforming growth factor-beta

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010215A1 (en) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Purified proteoglycan betaglycan, compositions, and methods
WO1997013844A1 (en) * 1995-10-06 1997-04-17 Cambridge Antibody Technology Limited Specific binding members for human transforming growth factor beta; materials and methods

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1993, TAHARA NAOKI ET AL: "Synthetic peptide-generated monoclonal antibodies to transforming growth factor-beta-1", XP002295801, Database accession no. PREV199396124237 *
DATABASE WPI Section Ch Week 199721, Derwent World Patents Index; Class B04, AN 1997-215360, XP002295802 *
HYBRIDOMA, vol. 12, no. 4, 1993, pages 441 - 453, ISSN: 0272-457X *
KROPF JUERGEN ET AL: "Immunological measurement of transforming growth factor-beta 1 (TGF-beta-1) in blood; assay development and comparison", CLINICAL CHEMISTRY, vol. 43, no. 10, 1997, pages 1965 - 1974, XP002295799, ISSN: 0009-9147 *
PERRY KENT T ET AL: "Transforming growth factor beta as a clinical biomarker for prostate cancer", UROLOGY, vol. 49, no. 1, 1997, pages 151 - 155, XP002295800, ISSN: 0090-4295 *
See also references of WO0062062A1 *
TEMPEST P R ET AL: "Human antibodies specific for human TGF-beta derived from phage display libraries", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 2, no. 4, 1 November 1996 (1996-11-01), pages 306, XP004063262, ISSN: 1380-2933 *

Also Published As

Publication number Publication date
TR200102917T2 (en) 2002-03-21
EP1166112A1 (en) 2002-01-02
NZ514596A (en) 2003-03-28
JP2002541479A (en) 2002-12-03
ID30316A (en) 2001-11-22
CN1355882A (en) 2002-06-26
AU768029B2 (en) 2003-11-27
AU4147100A (en) 2000-11-14
MXPA01009942A (en) 2003-07-14
WO2000062062A1 (en) 2000-10-19
BR0009607A (en) 2002-01-08
CA2369892A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
AU3781799A (en) Method and apparatus for subsurface imaging
AU5580499A (en) Foliar fertilizer and method for using the same
AU8579898A (en) Method for detecting interval changes in radiographs
AUPQ023299A0 (en) Cucurbiturils and method for synthesis
IL129355A0 (en) Method for preparing malonate methylidene nanoparticles nanoparticles optionally containing one or several biologically active molecules
HK1043363A1 (en) Method for producing 3-alkanoylindoles and 3-alkylindoles 3-.
AU3768299A (en) Apparatus and method for planting seismic sensors
GB2368641B (en) Methods and compositions for assaying analytes
AU2258399A (en) Method for irradiating an item
AU2308900A (en) Analysis method
AU4848099A (en) Merchant analysis support method
AU1393400A (en) Method for preparing 4-hydroquinolines and/or tautomeric compounds
EP1166112A4 (en) Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same
AU5890099A (en) Method and device for composting
AU4605099A (en) Method for detecting infection-phase-specific antibodies
AU1168000A (en) Device for supporting and/or guiding objects and method for setting said deviceson said objects
AU3421701A (en) Method for collecting and supplying information
EP1103814A4 (en) Method for assaying physiologically active component
AU2001294492A1 (en) Method and system for measuring objects
GB0017586D0 (en) Method and means for particle measurement
GB9806149D0 (en) Method and means for moving objects
HUP0101730A3 (en) Method for preparing and using b-starch
WO2001041007A8 (en) System and method for an internet-based consumer-to-business value cycle
AU1173101A (en) Biological deposit system and method
AU3306800A (en) Template and method for use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011027

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LIM, CHANG-GI

Inventor name: SHIN, HOON

Inventor name: JIN, SEUNG WON

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/574 B

Ipc: 7C 07K 16/22 B

Ipc: 7G 01N 33/53 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040929

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041216